Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US

NCT07431086 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight or Obesity

Interventions

DRUG: Olatorepatide
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals